GMP PRICE
![Bansal Wire IPO booked 59.5 times on last day. Check GMP and other details](https://img.etimg.com/thumb/msid-111510162,width-100,height-75,resizemode-4/markets/stocks/news/bansal-wire-ipo-booked-nearly-19x-so-far-on-last-day-check-gmp-and-other-details.jpg)
Bansal Wire IPO booked 59.5 times on last day. Check GMP and other details
The overall subscription stood at 18.78x so far. The categories reserved for NII and QIB investors were subscribed 34 times and 21 times, respectively. Meanwhile, the retail portion of the issue was subscribed the least at 10.54 times.
![Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details](https://img.etimg.com/thumb/msid-111509263,width-100,height-75,resizemode-4/markets/ipos/fpos/emcure-pharmaceuticals-ipo-booked-over-13-times-so-far-on-day-3-check-gmp-and-other-details.jpg)
Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details
Emcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmaceutical products. Revenue growth and plans for debt payment outlined. Book-running lead managers identified.
![Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details](https://img.etimg.com/thumb/msid-111449783,width-100,height-75,resizemode-4/markets/ipos/fpos/emcure-pharmaceuticals-ipo-check-subscription-on-day-1-gmp-and-other-details.jpg)
Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details
Emcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business improvements and revenue growth potential in the global pharmaceutical market, supporting the company's expansion strategies.
![Nephro Care shares list at 90% premium on NSE SME platform](https://img.etimg.com/thumb/msid-111503443,width-100,height-75,resizemode-4/markets/stocks/news/nephro-care-shares-list-at-90-premium-on-nse-sme-platform.jpg)
Nephro Care shares list at 90% premium on NSE SME platform
Nephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed by over 700 times. The company aims to establish a 100-bed multispeciality hospital in Kolkata using proceeds from the IPO. Nephro Care, led by Dr. Pratim Sengupta, focuses on comprehensive medical services for renal patients.
![Effwa Infra and Research IPO opens today: Check issue size, price band, GMP and other details](https://img.etimg.com/thumb/msid-111503153,width-100,height-75,resizemode-4/markets/ipos/fpos/effwa-infra-and-research-ipo-opens-today-check-issue-size-price-band-gmp-and-other-details.jpg)
Effwa Infra and Research IPO opens today: Check issue size, price band, GMP and other details
Effwa Infra and Research IPO is now open for subscription, aiming to raise Rs 51.27 crore. The company offers engineering and project management services in water pollution control. Investors can bid for shares at Rs 78-82 apiece.
![Ganesh Green Bharat IPO opens today: Check issue size, price band, GMP and other details](https://img.etimg.com/thumb/msid-111503071,width-100,height-75,resizemode-4/markets/ipos/fpos/ganesh-green-bharat-ipo-opens-today-check-issue-size-price-band-gmp-and-other-details.jpg)
Ganesh Green Bharat IPO opens today: Check issue size, price band, GMP and other details
Ganesh Green Bharat IPO will open for subscription, aiming to raise Rs 125 crore for solar and electrical projects. The company's diversified business model and strong financial performance make it a potential investment opportunity.
- Go To Page 1
Ambey Laboratories opens today: Check issue size, price band, GMP & other details
Ambey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenue and Rs 6.02 crore profit, it's set to list on NSE SME.
Vraj Iron and Steel makes a healthy debut. What should investors do now?
Vraj Iron and Steel has a proven track record of consistent profitability over the past three years, demonstrating its ability to generate healthy returns. However, analysts said investors should acknowledge certain risks, such as the concentration of manufacturing facilities in a single region and the lack of long-term customer contracts.
Bansal Wire IPO to open for subscription on Wednesday. Here's what GMP indicates
The company aims to raise approximately Rs 745 crore at the upper end of its price band. Investors can bid for a minimum of 58 shares per lot, with the option to bid in multiples of this lot size. Prior to the IPO subscription, the company's shares were trading at a premium of Rs 65 in the unlisted market.
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription
Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.
Allied Blenders and Distillers shares list at 14% premium over issue price
Allied Blenders, post IPO debut, saw a 14% premium. The company holds 8% IMFL market share in India. Revenue grew by 9% and profit after tax by 50%. Facing financial volatility, it expanded the product portfolio with a strong brand presence.
Bansal Wire IPO opens Wednesday: Here are 10 things to know about the public offer
The IPO of Bansal Wire is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 745 crore through this public offering. This IPO consists entirely of a fresh equity sale of 2.91 crore shares, with no OFS component involved. According to market analysts, Bansal Wire currently commands a GMP of Rs 65 in the unlisted market.
Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue
Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.
Vraj Iron and Steel IPO share allotment likely today. Here's how you can check status
Vraj Iron and Steel IPO, oversubscribed 100 times, plans to utilize proceeds for Bilaspur plant expansion. The company's shares trade at a premium in the unlisted market. Product offerings include TMT bars and Dolochar. Loan from HDFC Bank to be repaid with IPO funds, with internal accruals contributing to the balance amount.
Nephro Care IPO opens today: Check issue size, price band, GMP and other details
Invest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.
Allied Blenders IPO: Check subscription on last day, GMP and other details
The IPO of Allied Blenders and Distillers was subscribed 23.49 times on its third and final day. NIIs show strong interest with 32 times subscription, followed by retail investors at 4.42 times. The QIB portion of the issue was booked 50 times. The IPO combines a Rs 1,000 crore fresh equity sale and OFS of 1.77 crore shares, allowing promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra to reduce their stakes.
Vraj Iron and Steel IPO picks up pace on Day 2. Check subscription, GMP and other details
The initial public offer (IPO) of Vraj Iron and Steel picked up pace on the second day of the bidding process. The issue was subscribed over 8 times so far, driven by strong interest from retail and non-institutional investors.
Allied Blenders and Distillers IPO subscribed 1.51 times on Day 2. Check subscription, GMP and other details
ABDL's IPO involves a fresh equity sale of Rs 1,000 crore and an offer for sale (OFS) of 1.77 crore shares by promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra. Funds raised will repay borrowings and fund corporate needs. The company's shares are trading with a GMP of Rs 87.
Stanley Lifestyles IPO share allotment likely today. Check status, GMP, listing date and other details
Stanley Lifestyles, a luxury furniture brand in India, saw strong IPO response with 97 times oversubscription. The company plans to use the IPO proceeds for expansion and renovation of stores, showcasing growth in revenue and profit after tax.
Allied Blenders and Distillers IPO booked 51% on Day 1. Check GMP and other details
Allied Blenders & Distillers IPO saw 51% subscription with promoters planning stake sale. Revenue grew 9% year-on-year to Rs 5,915 crore. ICICI Securities, Nuvama Wealth Management, and ITI Capital are the book running lead managers for the IPO.
Medicamen Organics IPO booked 916 times at close; GMP at 147% over issue price
Medicamen Organics IPO, with 315 times subscription, plans to raise Rs 10.5 crore for expansion. The company aims to utilize net proceeds for international market registration and production capacity enhancement, targeting a share premium in the unlisted market.
Akme Fintrade shares to list tomorrow. What GMP signals ahead of listing?
With a strong financial performance and growth trajectory, our upcoming listing is poised for success. The oversubscribed IPO reflects investor confidence in our business model and potential for further expansion. Partnering with industry experts like Gretex Corporate Services ensures a solid foundation for future growth.
Ahead of IPO, Officer's Choice whisky maker Allied Blenders raises Rs 449 cr from anchor investors
The company has allocated 1.6 crore equity shares to 17 funds at Rs 281 each, the top of the price band, amounting to a deal size of Rs 449 crore, according to the report. The public offering, priced between Rs 267 and Rs 281 per share, aims to raise Rs 1,500 crore and will be open for subscription from June 25 to June 27.
Allied Blenders IPO to open on Tuesday. What GMP signals ahead of subscription?
Allied Blenders and Distillers, the maker of Officer's Choice Whiskey, is launching a Rs 1,500 crore IPO. The IPO is priced at Rs 267-281 per share, with a premium of Rs 75 in the unlisted market.
Sylvan Plyboard IPO opens: Check issue size, price band, GMP, and other details
Sylvan Plyboard IPO aims to raise about Rs 28.05 crore through the SME issue and list the shares on the NSE SME platform. The company's shares were trading with a GMP of 15 in the unlisted market.
Shivalic Power Control IPO opens today: Check issue size, price band, GMP and other details
Shivalic Power Control IPO aims to raise about Rs 64 crore through the SME IPO and list the shares on the NSE SME platform. The company is offering shares at Rs 95-100 apiece, and investors can bid for 1,200 shares in a lot.
Medicamen Organics IPO opens today: Check issue size, price band, GMP and other details
The SME IPO of Medicamen Organics commenced its subscription on Friday and is scheduled to conclude on June 24. The company intends to raise approximately Rs 10.54 crore through this offering. Once successfully subscribed, the shares will be listed on the BSE SME platform.
Winny Immigration IPO opens today: Check issue size, price band, GMP and other details
Winny Immigration's SME IPO, aiming to raise Rs 9.13 crore, opened for subscription and will close on June 24 on the NSE SME platform.
Ixigo shares debut at 48.5% premium over issue price
Ixigo IPO was booked nearly 98.34 times at close on strong interest from non-institutional and institutional buyers. Ahead of the listing, the company's shares traded with a premium of Rs 30 in the unlisted market.
Load More